Literature DB >> 3048331

Transactivation by the adenovirus E1A gene.

J R Nevins1, P Raychaudhuri, A S Yee, R J Rooney, I Kovesdi, R Reichel.   

Abstract

The 289aa product of the adenovirus E1A gene mediates the transcriptional activation of the set of early viral genes as well as several cellular genes. The E1A protein is not a DNA binding protein but, rather, acts indirectly to achieve the activation. The process of viral gene activation involves the use of cellular transcription factors, and in at least one case, in vivo assays have demonstrated a stimulation of stable promoter complex formation as a function of the E1A gene product. Analysis of transcription factors in nuclear extracts has identified a cellular factor, termed E2F, with specificity for the viral E2 promoter. The concentration of this factor increases as a result of the action of E1A. This increase in DNA binding activity does not require protein synthesis, thus indicating an E1A-mediated modification of a pre-existing factor. The E2F factor has been purified to homogeneity and is a polypeptide of 54,000 molecular weight. Analysis of an additional viral promoter, the E4 promoter, has identified a protein that interacts with sequences critical for transcription. This factor, termed E4F, is also increased as a function of the E1A product. The E4F factor has also been purified to homogeneity and has a molecular weight of 50,000. Therefore, the coordinate control of transcription by the E1A gene product involves the activation of multiple promoter specific factors.

Entities:  

Mesh:

Year:  1988        PMID: 3048331     DOI: 10.1139/o88-068

Source DB:  PubMed          Journal:  Biochem Cell Biol        ISSN: 0829-8211            Impact factor:   3.626


  8 in total

1.  The E4F protein is required for mitotic progression during embryonic cell cycles.

Authors:  Laurent Le Cam; Matthieu Lacroix; Maria A Ciemerych; Claude Sardet; Piotr Sicinski
Journal:  Mol Cell Biol       Date:  2004-07       Impact factor: 4.272

2.  Mutational analysis of the DRA promoter: cis-acting sequences and trans-acting factors.

Authors:  S Y Tsang; M Nakanishi; B M Peterlin
Journal:  Mol Cell Biol       Date:  1990-02       Impact factor: 4.272

3.  The adenovirus E4 17-kilodalton protein complexes with the cellular transcription factor E2F, altering its DNA-binding properties and stimulating E1A-independent accumulation of E2 mRNA.

Authors:  M J Marton; S B Baim; D A Ornelles; T Shenk
Journal:  J Virol       Date:  1990-05       Impact factor: 5.103

4.  In vivo association of E2F and DP family proteins.

Authors:  C L Wu; L R Zukerberg; C Ngwu; E Harlow; J A Lees
Journal:  Mol Cell Biol       Date:  1995-05       Impact factor: 4.272

5.  A novel hTERT promoter-driven E1A therapeutic for ovarian cancer.

Authors:  Xiaoming Xie; Jennifer L Hsu; Min-Gew Choi; Weiya Xia; Hirohito Yamaguchi; Chun-Te Chen; Bon Q Trinh; Zhen Lu; Naoto T Ueno; Judith K Wolf; Robert C Bast; Mien-Chie Hung
Journal:  Mol Cancer Ther       Date:  2009-08-11       Impact factor: 6.261

6.  Multiple domains in the 50 kDa form of E4F1 regulate promoter-specific repression and E1A trans-activation.

Authors:  Robert J Rooney
Journal:  Gene       Date:  2020-06-11       Impact factor: 3.688

7.  Interaction of the 72-kilodalton human cytomegalovirus IE1 gene product with E2F1 coincides with E2F-dependent activation of dihydrofolate reductase transcription.

Authors:  M J Margolis; S Pajovic; E L Wong; M Wade; R Jupp; J A Nelson; J C Azizkhan
Journal:  J Virol       Date:  1995-12       Impact factor: 5.103

8.  Heat Shock Protein 90 Chaperones E1A Early Protein of Adenovirus 5 and Is Essential for Replication of the Virus.

Authors:  Iga Dalidowska; Olga Gazi; Dorota Sulejczak; Maciej Przybylski; Pawel Bieganowski
Journal:  Int J Mol Sci       Date:  2021-02-18       Impact factor: 5.923

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.